Serrapeptase
Serrapeptase (Serratiopeptidase)
Proteolytic enzyme that may help with inflammation, mucus clearance, and tissue healing.
Serrapeptase is a proteolytic enzyme originally isolated from the silkworm. It breaks down proteins involved in inflammation and scar tissue, and may help thin mucus. Popular in Europe and Japan for post-surgical recovery, sinusitis, and inflammatory conditions. Used as an alternative to NSAIDs for pain and swelling.
Mechanisms of Action
Proteolytic Activity
Breaks down inflammatory proteins
Mucolytic Effect
Thins and clears mucus
Recommended Dose
120,000-240,000 SPU (serrapeptase units)
Optimal Timing
- On empty stomach
- 30 min before or 2 hours after meals
Can be taken without food
Best Form
Enteric-coated capsules (protects from stomach acid)
Alternatives: Delayed-release tablets
Enteric coating is essential — stomach acid destroys unprotected serrapeptase.
Duration
Minimum: 2 weeks
Optimal: 4 weeks
Cycling: Not required
Note: MUST be taken on empty stomach for systemic effects. Food inactivates the enzyme.
Personalized Dosage Calculator
Get a dosage recommendation tailored to your body weight, age, goals, and health profile.
Set up your health profile for personalized recommendations
Reduced Swelling
Less edema and inflammation
Sinus Relief
Improved mucus drainage
Insufficient data; avoid
Who Should NOT Take This
- Bleeding disorders
- Before surgery (stop 2 weeks prior)
Drug Interactions
May increase bleeding risk
May increase antibiotic tissue levels
Possible Side Effects
Tip: Use enteric-coated; take on empty stomach
Tip: Discontinue if rash develops
Warnings
- Stop 2 weeks before surgery
- Empty stomach is essential
- Must use enteric-coated form
Top studies from 19+ peer-reviewed papers
Zakarija-Grkovic I et al. • The Cochrane database of systematic reviews (2020)
“Although some interventions may be promising for the treatment of breast engorgement, such as cabbage leaves, cold gel packs, herbal compresses, and massage, the certainty of evidence is low and we cannot draw robust conclusions about their true effects.”
Key Findings:
- For breast hardness, cold cabbage leaves may be more effective than routine care (MD -0.58 VAS points, 95% CI -0.82 to -0.34; 152 women; low-certainty evidence).
- For breast engorgement, room temperature cabbage leaves may be more effective than a hot water bag (MD -1.16 points on 1-6 scale, 95% CI -1.36 to -0.96; 63 women; very low-certainty evidence).
- More women were satisfied with cold cabbage leaves than with routine care (risk ratio (RR) 1.42, 95% CI 1.22 to 1.64; 152 women; low certainty), or with cold gel packs (RR 1.23, 95% CI 1.10 to 1.38; 152 women; low-certainty evidence).
- Compress treatments compared to control For breast pain, herbal compress may be more effective than hot compress (MD -1.80 VAS points, 95% CI -2.07 to -1.53; 500 women; low-certainty evidence).
Patil SD et al. • Annales pharmaceutiques francaises (2024)
“All rights reserved.”
Key Findings:
- Serratiopeptidase topical formulations could be more effective than nonsteroidal anti-inflammatory medications in treating local inflammation.
- This article reviews studies on various topical formulations.Copyright © 2024 Académie Nationale de Pharmacie.
- Published by Elsevier Masson SAS.
- All rights reserved.
Hosseini SB et al. • Archives of microbiology (2024)
“The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.”
Key Findings:
- To overcome such limitations, improved versions of the enzyme were introduced using protein engineering in our previous studies.
- Novel functional serratiopeptidases with shorter length and higher stability have seemingly created a hope for using this enzyme as a more effective therapeutic enzyme.
- The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Nair SR et al. • Biomolecules (2022)
“In addition, the review highlights the therapeutic and clinical aspects of the serratiopeptidase enzyme to combat COVID-19-induced respiratory syndrome.”
Key Findings:
- Existing serratiopeptidase treatments in combination with antibiotics are popular in the treatment of postoperative swelling.
- Although an exclusive number of serratiopeptidase-producing strains have been derived, there is an urge for new recombinant strains to enhance the production of the enzyme.
- This review explores the properties of serratiopeptidase, different therapeutic aspects, industrial production, and various analytical techniques used in enzyme recovery.
- In addition, the review highlights the therapeutic and clinical aspects of the serratiopeptidase enzyme to combat COVID-19-induced respiratory syndrome.
Tamimi Z et al. • BMC oral health (2021)
“Serratiopeptidase resulted in better inflammation improvement than placebo over 5 days.”
Key Findings:
- In this clinical trail 133 patients (mean age 23 years, 54% female) completed the study.
- Serratiopeptidase resulted in better inflammation improvement than placebo over 5 days.
- Further studies are warranted to assess longer-term and clinical outcomes, as well as safety.
Study Type Distribution
Goals This Supplement Supports
This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.